ImClone Systems Biopharmaceutical Plant, Branchburg, NJ, USA

Imclone Systems Incorporated's biopharmaceutical manufacturing facility in Branchburg, New Jersey, was approved by the FDA in July 2002 to produce investigational quantities of Erbitux (IMC-C225).


		Next»

| 1 | 2 | 3 | 4 | 5 | 6 | 7 |

Browse More Images - Return to Project